Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R
Department of Cardiothoracic Sciences, Second University of Naples, Monaldi Hospital, Naples, Italy.
Minerva Cardioangiol. 2010 Feb;58(1):35-40.
Contrast-induced nephropathy (CIN) is most commonly defined as acute renal failure occurring within 48-72 h of exposure to intravascular radiographic contrast medium that is not attributable to other causes. In international literature a 25% increase in serum creatinine levels or an increase in absolute values of 0.5 mg/dL from baseline has been suggested to define CIN. The reported incidence of CIN varies widely, ranging from 2% to 50%. This variability results from differences in the presence or absence of risk factors. With a retrospective analysis authors evaluated the use of NaCl saline hydration and N-acetyl cysteine (NAC) to prevent CIN in different populations of patients at high and low risk undergoing coronary artery angiography.
From January 2007 to December 2008, 597 patients underwent coronary artery angiography with a low osmolarity contrast agent. Nephrotoxic drugs such as diuretics, metformin, ACE-I and ARBs were stopped at least 24 h before the procedure. The population was divided into two groups: group A (high risk 342 patients, 57.2%) identified for the presence of at least one risk factor such as diabetes, age >65 years, baseline creatinine >1.4 mg/dL and group B (low risk 255 patients, 42.8%) for the absence of any of the risk mentioned above. Only group A was treated with a saline hydration (1 mL/kg/h) plus NAC 600 mg 12 h before and 12 h after the procedure.
The overall incidence of CIN was 6.7% (40 patients). In particular, the incidence of CIN was 4.4% (15 patients) in the group A and 9.8% (25 patients) in the group B respectively (P=0.017). Interestingly, the Contrast Index (volume administrated/theoretical maximum volume) was significantly lower in group B (P<0.005). In the multivariate analysis, including risk factors such as age, diabetes, hypertension, hypercholesterol-mia, current smoke, baseline creatinine level, Contrast Index and hydration, the last variable was the only one inversely correlated independently with the incidence of CIN (P=0.001).
The hydration with saline and NAC is an effective and low-cost tool in preventing CIN in patients undergoing coronary artery angiography and, according to the current guidelines, should be used in all high-risk patients. Present results show that even in patients at low risk for CIN, hydration could be useful: in fact, despite the Contrast Index was significantly lower in this population, the incidence of CIN was greater, thus suggesting a potential role for hydration also in the low-risk population.
对比剂肾病(CIN)最常被定义为在血管内注射造影剂后48 - 72小时内发生的急性肾衰竭,且无其他病因可解释。国际文献中建议血清肌酐水平升高25%或较基线绝对值升高0.5mg/dL可定义为CIN。报道的CIN发病率差异很大,从2%到50%不等。这种差异源于危险因素的有无。作者通过回顾性分析评估了生理盐水水化和N - 乙酰半胱氨酸(NAC)在接受冠状动脉造影的不同高危和低危患者群体中预防CIN的作用。
2007年1月至2008年12月,597例患者接受了低渗造影剂冠状动脉造影。在检查前至少24小时停用利尿剂、二甲双胍、ACE - I和ARB等肾毒性药物。将患者分为两组:A组(高危组342例,57.2%),存在至少一种危险因素,如糖尿病、年龄>65岁、基线肌酐>1.4mg/dL;B组(低危组255例,42.8%),不存在上述任何危险因素。仅A组在检查前12小时和检查后12小时接受生理盐水水化(1mL/kg/h)加600mg NAC治疗。
CIN的总体发病率为6.7%(40例患者)。具体而言,A组CIN发病率为4.4%(15例患者),B组为9.8%(25例患者)(P = 0.017)。有趣的是,B组的造影剂指数(注射量/理论最大量)显著更低(P < 0.005)。在多因素分析中,纳入年龄、糖尿病、高血压、高胆固醇血症、当前吸烟、基线肌酐水平、造影剂指数和水化等危险因素,最后一个变量是唯一与CIN发病率独立呈负相关的因素(P = 0.001)。
生理盐水水化和NAC是预防接受冠状动脉造影患者发生CIN的有效且低成本的方法,根据当前指南,应在所有高危患者中使用。目前的结果表明,即使在CIN低危患者中,水化也可能有用:事实上,尽管该人群的造影剂指数显著更低,但CIN发病率更高,因此提示水化在低危人群中也可能发挥作用。